Springboard Health Angels

At CGC Genomics (CGC) we are deeply committed to advancing the field of cancer care through complex, precision genomics analysis and report interpretation. We distill complex genomic data into concise, actionable insights for healthcare providers, reducing interpretation times and facilitating timely, personalized treatment recommendations for 10 million patients with metastatic cancer.​ Our years of experience interpreting and supporting thousands of the most complicated cancer genomics cases around the world enables CGC to offer healthcare providers timely, expert cancer genomics analysis and consultation support, delivering world-class expertise wherever and whenever needed.

Vivalyx operates a patented organ preservation system designed to enhance the success of organ transplantation. Its technology combines static cold storage with machine perfusion, offering a blood-free alternative that aims to increase the vitality and availability of donor organs, thereby improving patient outcomes.

Yoneda Labs is a developer of AI-based software designed to assist chemists in optimizing reaction parameters essential for the synthesis of drugs and materials. The platform enables users to determine critical factors such as temperature, concentration, and catalyst, thereby enhancing the efficiency and speed of chemical laboratory processes. By leveraging advanced artificial intelligence, Yoneda Labs aims to streamline the development of chemical reactions, ultimately facilitating faster innovation in the pharmaceutical and material sciences industries.

deepeye is a company that develops an AI-powered precision medicine platform for retinal diseases. The platform enables ophthalmologists to tailor therapies for conditions such as age-related macular degeneration and other retinal disorders by analyzing therapy data and providing second opinions on treatment needs and scheduling. It serves clinicians, pharmaceutical developers, payors, and provider associations to improve therapy outcomes and prevent vision loss.

PharmaCCX is a healthcare technology company established in 2017, headquartered in Boston with additional offices in Stockholm, San Mateo, and Zug. It operates a platform that facilitates pricing negotiations and procurement processes between oncology pharmaceutical companies and healthcare payers, aiming to accelerate patient access to necessary medicines. The platform offers a configurable infrastructure for planning, negotiating, and managing deals, enabling market access teams at pharma companies and payers to efficiently administer innovative payment models.

Tech-enabled healthcare solution for the underserved LGBTQIA+ community.

LEVY Health specializes in clinical decision support software focused on endocrine disorders. Its platform employs proprietary algorithms and clinical guidelines to recommend ICD-10 diagnoses and individual therapeutic strategies, reducing the average time to diagnosis from approximately four years to just a few weeks.

Virtonomy GmbH is a Munich-based company that specializes in providing clinical trial services using virtual human, sheep, pig, and calf models. Founded in 2019, Virtonomy offers a platform that integrates digital twin models, AI, multi-physics simulations, and predictive analytics to enhance the development and evaluation of medical devices. The company delivers services such as anatomy studies, virtual fittings, pre-operative planning, and visualization through detailed image analysis and three-dimensional anatomical models. By enabling medical device manufacturers to optimize designs, reduce risks associated with anatomical variability, and develop patient-specific implants, Virtonomy facilitates a streamlined product development process. This approach not only shortens development timelines but also minimizes costs and risks linked to traditional clinical trials, allowing for safer and more efficient testing in a virtual environment.

Sensible Biotechnologies is developing a cell-based design, optimization, and manufacturing platform to enable next-generation messenger RNA medicines. The platform integrates cell engineering, computational biology, and precision fermentation to create and manufacture high-quality mRNA constructs with reduced immunogenicity. In particular, it focuses on optimizing the production of vaccinia capping enzymes to improve the stability and translation of therapeutic mRNA, supporting the creation of vaccines and medicines that are more effective and accessible. The approach aims to streamline development from design to production, reducing time and cost in bringing mRNA therapies to patients.

Acorai develops a non-invasive heart failure monitoring platform centered around direct intracardiac pressure monitoring. Its patented technology combines sensor technologies and machine learning to enable accurate, cost-efficient care, reducing re-hospitalization and mortality rates.

Syndi is a digital health support recommendation platform that utilizes machine learning and digital phenotyping, with a primary focus on mental health. The company develops technology-driven solutions aimed at enhancing individuals' health by providing effective and accessible support. Syndi's platform employs passive smartphone data collection to gather moment-to-moment information about users, allowing it to deliver personalized and immediate care. This innovative approach not only facilitates connections between patients and healthcare providers but also measures the effectiveness of applications and digital services in treating invisible disabilities. Through its commitment to leveraging technology and research, Syndi seeks to improve healthcare outcomes for its users.

Recovery Cat provides a therapy collaboration platform for patients with severe mental disorders, enabling collective therapy planning and evaluation and delivering insights to doctors and patients by monitoring responses to treatments for schizophrenia, bipolar disorder and recurrent depression, helping psychiatrists tailor medications, identify at-risk patients, and support engagement to prevent relapses through personalized follow-ups and data-driven insights.

Mirantus Health improves access to specialist healthcare for underserved patients by empowering doctors through its digital-hybrid services. These services combine point-of-care diagnostics with telemedicine, allowing specialists to diagnose and treat patients remotely. This approach enhances patient care, increases physician earnings, and reduces downstream costs for payors.

Akina is a Swiss company founded in 2021, headquartered in Zurich, that specializes in developing artificial intelligence healthcare software. The company focuses on enhancing physiotherapy by providing a platform that empowers patients to engage in independent therapy at home. Through its innovative software, Akina connects patients with healthcare providers for remote therapeutic monitoring and personalized guidance. The platform utilizes proprietary AI motion analysis and media streaming algorithms to facilitate automated case reviews and generate feedback for therapists. This approach aims to improve clinical outcomes and enhance the efficiency of care delivery, merging evidence-based therapy with engaging entertainment for a comprehensive treatment experience.

Phinomics is a precision-medicine company specializing in circular-DNA targets for personalized healthcare. It employs reproducible science, novel technologies, proprietary workflows, informatics/AI, and single-cell analysis to identify and validate unique pathology-specific circular-DNAs, addressing unmet clinical needs with high resolution.

Rekoo is an online clinic for stroke healing. They provide optimal care for every stroke patient by returning them to the center. They offer care systems, but they don't find the support they need, resulting in deficient recovery outcomes and skyrocketing care costs.